HDAC6 inhibitor WT161 induces apoptosis in retinoblastoma cells and synergistically interacts with cisplatin

BACKGROUND: WT161 is a recently discovered histone deacetylase 6 (HDAC6) inhibitor which shows anti-tumor effects on multiple myelomas and breast cancer. However, the role of WT161 in retinoblastoma remains unclear. The aim of this study is to explore the role of WT161 in retinoblastoma and its unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jun, Qian, Xia, Zhang, Feifei, Tang, Xiaofeng, Ju, Cheng, Liu, Renfeng, Zhou, Ruihao, Zhang, Zhiping, Lv, Xiao-Bin, Zhang, Changhua, Huang, Guofu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798655/
https://www.ncbi.nlm.nih.gov/pubmed/35117033
http://dx.doi.org/10.21037/tcr.2019.10.30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798655/
https://www.ncbi.nlm.nih.gov/pubmed/35117033
http://dx.doi.org/10.21037/tcr.2019.10.30

Ejemplares similares